Windtree Therapeutics issues $312.5K in senior secured convertible notes at 20% OID for net proceeds of $250K

WINDTREE THERAPEUTICS INC /DE/

Aggregate principal $312,500 with 20% OID; net proceeds $250,000 from two institutional investors.
Notes mature Jan 4, 2026; 10% interest payable monthly; mandatory prepayment of 25% of gross proceeds from future common stock purchase agreement with 120% premium.
Conversion price $1.10 per share; anti-dilution adjustment if subsequent equity sales at lower price.
Company must file registration statement on Form S-1 for resale of conversion shares within 20 days.
Events of Default trigger additional interest of 2% per month (24% per annum).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.